liver cancer
Neonatal HBV Vaccination Reduces Liver Cancer Risk
A follow-up study spanning 30 years shows that vaccinating babies against HBV reduces their risk of liver disease in adulthood.
Taking AIM At Liver Cancer
Scientists have found that the protein AIM stops liver cancer in its tracks in mice, suggesting a possible treatment for human patients.
HCV Genotype 1 Most Prevalent Worldwide
One third of the world's 83 million genotype 1 carriers reside in East Asia.
Antivirals Reduce Liver Disease Risk
Two independent studies show that treating hepatitis B early with antiviral drugs can reduce the risk of developing liver disease.
NeoStem & CBMG Embark On Phase II Trial For Liver Cancer
The Phase II trial for patients with late stage liver cancer will examine the effectiveness of a dendritic cell-based therapy.
SIMM, Crown BioScience To Build Mouse Xenograft Model Center
Shanghai Institute of Materia Medica and Crown BioScience, Inc. have agreed to jointly build a mouse clinical trial center in China.
Men-Only Hepatitis B Mutation Explains Higher Cancer Rates
A mutation in the hepatitis B virus (HBV) that appears only in men could explain why HBV-infected men have much higher liver cancer rates.
MicroConstants China Licenses Liver Cancer Drug From Pertinax Therapeutics
MicroConstants China Inc. has licensed the China rights for a Phase II liver cancer drug candidate, PTX-9908, from Pertinax Therapeutics of Canada.
First Major Study Of Cancer Incidence In Asian Americans
Scientists have completed the first ever analysis of national trends in cancer incidence among the eight largest Asian American groups.
